Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CPG, Inc. is a premier developer and manufacturer of high-performance solid support materials used in the synthesis of DNA and RNA oligonucleotides. The company is best known for its proprietary Controlled Pore Glass (CPG) technology, which provides the essential physical and chemical framework for automated phosphoramidite synthesis. These materials are critical for the production of therapeutic oligonucleotides, diagnostic probes, and genetic research tools. Following its acquisition by LGC, the company continues to serve as a vital supplier to the global biotechnology and pharmaceutical industries, enabling the development of next-generation genomic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CPG International.